151 related articles for article (PubMed ID: 14570763)
21. Functional and biological determinants affecting the duration of action and efficacy of anti-(+)-methamphetamine monoclonal antibodies in rats.
Laurenzana EM; Hendrickson HP; Carpenter D; Peterson EC; Gentry WB; West M; Che Y; Carroll FI; Owens SM
Vaccine; 2009 Nov; 27(50):7011-20. PubMed ID: 19800446
[TBL] [Abstract][Full Text] [Related]
22. PEGylation of a High-Affinity Anti-(+)Methamphetamine Single Chain Antibody Fragment Extends Functional Half-Life by Reducing Clearance.
Reichard EE; Nanaware-Kharade N; Gonzalez GA; Thakkar S; Owens SM; Peterson EC
Pharm Res; 2016 Dec; 33(12):2954-2966. PubMed ID: 27620175
[TBL] [Abstract][Full Text] [Related]
23. First human study of a chimeric anti-methamphetamine monoclonal antibody in healthy volunteers.
Stevens MW; Henry RL; Owens SM; Schutz R; Gentry WB
MAbs; 2014; 6(6):1649-56. PubMed ID: 25484042
[TBL] [Abstract][Full Text] [Related]
24. Using hapten design to discover therapeutic monoclonal antibodies for treating methamphetamine abuse.
Peterson EC; Gunnell M; Che Y; Goforth RL; Carroll FI; Henry R; Liu H; Owens SM
J Pharmacol Exp Ther; 2007 Jul; 322(1):30-9. PubMed ID: 17452421
[TBL] [Abstract][Full Text] [Related]
25. Effects of murine-derived anti-methamphetamine monoclonal antibodies on (+)-methamphetamine self-administration in the rat.
McMillan DE; Hardwick WC; Li M; Gunnell MG; Carroll FI; Abraham P; Owens SM
J Pharmacol Exp Ther; 2004 Jun; 309(3):1248-55. PubMed ID: 14993256
[TBL] [Abstract][Full Text] [Related]
26. The pharmacokinetics of methamphetamine self-administration in male and female rats.
Milesi-Hallé A; Hambuchen MD; McMillan DE; Michael Owens S
Drug Alcohol Depend; 2015 May; 150():164-9. PubMed ID: 25796510
[TBL] [Abstract][Full Text] [Related]
27. Vulnerability to (+)-methamphetamine effects and the relationship to drug disposition in pregnant rats during chronic infusion.
White SJ; Laurenzana EM; Gentry WB; Hendrickson HP; Williams DK; Ward KW; Owens SM
Toxicol Sci; 2009 Sep; 111(1):27-36. PubMed ID: 19520673
[TBL] [Abstract][Full Text] [Related]
28. Methamphetamine and amphetamine pharmacokinetics in oral fluid and plasma after controlled oral methamphetamine administration to human volunteers.
Schepers RJ; Oyler JM; Joseph RE; Cone EJ; Moolchan ET; Huestis MA
Clin Chem; 2003 Jan; 49(1):121-32. PubMed ID: 12507968
[TBL] [Abstract][Full Text] [Related]
29. Quantitative determination of total methamphetamine and active metabolites in rat tissue by liquid chromatography with tandem mass spectrometric detection.
Hendrickson H; Laurenzana E; Owens SM
AAPS J; 2006 Nov; 8(4):E709-17. PubMed ID: 17233534
[TBL] [Abstract][Full Text] [Related]
30. Bioavailability of (+)-methamphetamine in the pigeon following an intramuscular dose.
Hendrickson HP; Hardwick WC; McMillan DE; Owens SM
Pharmacol Biochem Behav; 2008 Sep; 90(3):382-6. PubMed ID: 18455783
[TBL] [Abstract][Full Text] [Related]
31. A Nanotechnology-Based Platform for Extending the Pharmacokinetic and Binding Properties of Anti-methamphetamine Antibody Fragments.
Nanaware-Kharade N; Thakkar S; Gonzalez GA; Peterson EC
Sci Rep; 2015 Jul; 5():12060. PubMed ID: 26159352
[TBL] [Abstract][Full Text] [Related]
32. Monoclonal IgG affinity and treatment time alters antagonism of (+)-methamphetamine effects in rats.
Byrnes-Blake KA; Laurenzana EM; Landes RD; Gentry WB; Owens SM
Eur J Pharmacol; 2005 Oct; 521(1-3):86-94. PubMed ID: 16182279
[TBL] [Abstract][Full Text] [Related]
33. A methamphetamine vaccine attenuates methamphetamine-induced disruptions in thermoregulation and activity in rats.
Miller ML; Moreno AY; Aarde SM; Creehan KM; Vandewater SA; Vaillancourt BD; Wright MJ; Janda KD; Taffe MA
Biol Psychiatry; 2013 Apr; 73(8):721-8. PubMed ID: 23098894
[TBL] [Abstract][Full Text] [Related]
34. Generation of anti-(+)methamphetamine antibodies is not impeded by (+)methamphetamine administration during active immunization of rats.
Byrnes-Blake KA; Carroll FI; Abraham P; Owens SM
Int Immunopharmacol; 2001 Feb; 1(2):329-38. PubMed ID: 11360933
[TBL] [Abstract][Full Text] [Related]
35. (+)-Methamphetamine-induced spontaneous behavior in rats depends on route of (+)METH administration.
Gentry WB; Ghafoor AU; Wessinger WD; Laurenzana EM; Hendrickson HP; Owens SM
Pharmacol Biochem Behav; 2004 Dec; 79(4):751-60. PubMed ID: 15582684
[TBL] [Abstract][Full Text] [Related]
36. Distribution of methamphetamine and its metabolite amphetamine in acute and subacute ethanol-methamphetamine combination abuse model rats.
Liang M; Liu Y; Zheng N; Ananda S; Liu L
J Anal Toxicol; 2012; 36(1):30-5. PubMed ID: 22290750
[TBL] [Abstract][Full Text] [Related]
37. Effects of active anti-methamphetamine vaccination on intravenous self-administration in rats.
Miller ML; Aarde SM; Moreno AY; Creehan KM; Janda KD; Taffe MA
Drug Alcohol Depend; 2015 Aug; 153():29-36. PubMed ID: 26118833
[TBL] [Abstract][Full Text] [Related]
38. The anti-(+)-methamphetamine monoclonal antibody mAb7F9 attenuates acute (+)-methamphetamine effects on intracranial self-stimulation in rats.
Harris AC; LeSage MG; Shelley D; Perry JL; Pentel PR; Owens SM
PLoS One; 2015; 10(3):e0118787. PubMed ID: 25742165
[TBL] [Abstract][Full Text] [Related]
39. Antiphencyclidine monoclonal antibody therapy significantly changes phencyclidine concentrations in brain and other tissues in rats.
Valentine JL; Owens SM
J Pharmacol Exp Ther; 1996 Aug; 278(2):717-24. PubMed ID: 8768723
[TBL] [Abstract][Full Text] [Related]
40. Structural characterization of a therapeutic anti-methamphetamine antibody fragment: oligomerization and binding of active metabolites.
Peterson EC; Celikel R; Gokulan K; Varughese KI
PLoS One; 2013; 8(12):e82690. PubMed ID: 24349338
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
